HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Khalid Matrougui Selected Research

SB 223245

7/2008Microvessel vascular smooth muscle cells contribute to collagen type I deposition through ERK1/2 MAP kinase, alphavbeta3-integrin, and TGF-beta1 in response to ANG II and high glucose.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Khalid Matrougui Research Topics

Disease

8Type 2 Diabetes Mellitus (MODY)
06/2022 - 08/2008
7Hypertension (High Blood Pressure)
01/2019 - 07/2008
6Inflammation (Inflammations)
10/2022 - 01/2011
6Body Weight (Weight, Body)
11/2017 - 06/2012
4Fibrosis (Cirrhosis)
01/2016 - 07/2008
4Atherosclerosis
03/2011 - 04/2009
3Myocardial Infarction
01/2020 - 01/2018
3Cardiomegaly (Heart Hypertrophy)
01/2016 - 03/2011
3Ischemia
12/2012 - 07/2010
2Infarction (Infarctions)
01/2018 - 01/2018
2Neointima
02/2015 - 03/2013
2Hyperplasia
02/2015 - 03/2013
2Neoplasms (Cancer)
09/2013 - 01/2007
2Type 1 Diabetes Mellitus (Autoimmune Diabetes)
07/2012 - 07/2008
2Hypoxia (Hypoxemia)
07/2010 - 08/2008
1Cardiovascular Diseases (Cardiovascular Disease)
10/2022
1Insulin Resistance
01/2019
1Reperfusion Injury
01/2018
1AIDS-Related Complex (ARC)
03/2014
1Erectile Dysfunction
11/2013
1Glioblastoma (Glioblastoma Multiforme)
09/2013
1Carcinogenesis
01/2013
1Breast Neoplasms (Breast Cancer)
01/2013
1Vascular Remodeling
11/2012
1Dilated Cardiomyopathy (Cardiomyopathy, Congestive)
03/2011
1Pneumonia (Pneumonitis)
11/2009
1Hypercholesterolemia
11/2009
1Dyslipidemias (Dyslipidemia)
10/2009
1Myocardial Ischemia (Ischemic Heart Diseases)
06/2009
1Atherosclerotic Plaque (Atheroma)
04/2009

Drug/Important Bio-Agent (IBA)

9Proteins (Proteins, Gene)FDA Link
01/2018 - 01/2007
4Protein-Tyrosine Kinases (Tyrosine Kinase)IBA
01/2018 - 01/2010
4Angiotensin IIIBA
01/2018 - 07/2012
4Blood Glucose (Blood Sugar)IBA
01/2015 - 06/2012
4Poly(ADP-ribose) Polymerases (Poly ADP Ribose Polymerase)IBA
05/2012 - 04/2009
3ursodoxicoltaurineIBA
01/2018 - 06/2012
3Insulin (Novolin)FDA Link
11/2017 - 06/2012
3NADP (NADPH)IBA
01/2016 - 11/2013
3Apolipoproteins E (ApoE)IBA
03/2011 - 10/2009
2Interleukin-10 (Interleukin 10)IBA
01/2019 - 11/2011
2EnzymesIBA
01/2019 - 02/2015
2Mitogen-Activated Protein Kinase 3IBA
01/2018 - 01/2012
2Glucose (Dextrose)FDA LinkGeneric
11/2017 - 06/2015
2Oxidoreductases (Dehydrogenase)IBA
01/2016 - 11/2013
2Small Interfering RNA (siRNA)IBA
02/2015 - 07/2008
2NADPH Oxidases (NAD(P)H oxidase)IBA
04/2014 - 11/2011
2Calcium Release Activated Calcium ChannelsIBA
03/2014 - 09/2013
2Leukotriene C4IBA
03/2014 - 03/2013
2Nitric Oxide (Nitrogen Monoxide)FDA Link
11/2013 - 12/2012
2Collagen Type I (Type I Collagen)IBA
07/2012 - 07/2008
2Plasminogen Activator Inhibitor 1IBA
07/2012 - 08/2008
2ErbB Receptors (EGF Receptor)IBA
07/2012 - 01/2012
2CollagenIBA
07/2012 - 11/2009
2Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
01/2011 - 11/2009
2ApolipoproteinsIBA
10/2009 - 04/2009
1HMGB1 Protein (HMG1)IBA
10/2022
1NADH DehydrogenaseIBA
06/2022
1InterleukinsIBA
01/2020
1Cytochrome P-450 CYP2E1 (CYP2E1)IBA
01/2019
1allyl sulfideIBA
01/2019
1triphenyltetrazoliumIBA
01/2018
1MitogensIBA
01/2018
1Proto-Oncogene Proteins c-akt (Protein Kinase B)IBA
01/2018
1Phosphotransferases (Kinase)IBA
01/2018
1Interleukin-12 (IL 12)IBA
11/2017
1Vascular Endothelial Growth Factor Receptor-2 (Vascular Endothelial Growth Factor Receptor 2)IBA
11/2017
1Nitric Oxide Synthase Type III (Endothelial Nitric Oxide Synthase)IBA
11/2017
1Stromal Interaction Molecule 1IBA
01/2016
1CCAAT-Enhancer-Binding ProteinsIBA
01/2016
1Transforming Growth Factors (Transforming Growth Factor)IBA
01/2016
1leukotriene-C4 synthaseIBA
02/2015
14- ethoxymethylene- 2- phenyl- 2- oxazoline- 5- one (phOx)IBA
04/2014
1Arachidonic Acid (Vitamin F)IBA
03/2014
1EscitalopramFDA Link
11/2013
1Reactive Oxygen Species (Oxygen Radicals)IBA
11/2013
1Vasodilator Agents (Vasodilators)IBA
10/2013
1Protein Isoforms (Isoforms)IBA
09/2013
1Estrogen ReceptorsIBA
01/2013
1NG-Nitroarginine Methyl Ester (L-NAME)IBA
12/2012
1Sodium NitriteIBA
12/2012
1NitritesIBA
12/2012
1Nitric Oxide Synthase (NO Synthase)IBA
07/2012
1Streptozocin (Streptozotocin)FDA Link
07/2012
1Therapeutic UsesIBA
07/2012
1RTKI cpdIBA
07/2012
1Interleukin 1 Receptor Antagonist Protein (Anakinra)FDA Link
06/2012
1Extracellular Signal-Regulated MAP Kinases (Extracellular Signal Regulated Kinases)IBA
01/2012
1Tissue Inhibitor of Metalloproteinase-2IBA
03/2011
1Tissue Inhibitor of MetalloproteinasesIBA
03/2011
1Matrix Metalloproteinases (MMPs)IBA
03/2011
1Acetylcholine (Acetylcholine Chloride)FDA Link
01/2011
1Vascular Endothelial Growth Factor Receptors (VEGF Receptors)IBA
07/2010
1Matrix Metalloproteinase 9 (Gelatinase B)IBA
11/2009
1Chemokine CCL3IBA
11/2009
1Epidermal Growth Factor (EGF)IBA
06/2009
1LipidsIBA
04/2009
1Poly(ADP-ribose) Polymerase InhibitorsIBA
04/2009

Therapy/Procedure

6Therapeutics
01/2019 - 01/2007
2Ligation
12/2012 - 07/2010
1Surgical Amputation (Amputations)
07/2010